| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| TTX-030 | TTX-030 | Phase 2 Clinical | Adimab LLC | Solid tumours; Pancreatic Neoplasms; Lymphoma | 詳細 |
| IPH-5201 | IPH-5201 | Phase 2 Clinical | Inserm, Orega Biotech | Solid tumours; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | 詳細 |
| Perenostobart | SRF-617 | Phase 2 Clinical | Surface Oncology Inc | Solid tumours; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | 詳細 |
| JS-019 | JS-019 | Phase 1 Clinical | Beijing Enrini Biotechnology Co Ltd | Solid tumours; Eosinophilia; Lymphoma | 詳細 |
| ES-014 | ES-014 | Phase 1 Clinical | Solid tumours; Neoplasms; Neoplasm Metastasis | 詳細 | |
| PUR-001 | PUR-001 | Phase 1 Clinical | Purinomia Biotech Inc | Solid tumours | 詳細 |
| AB-598 | AB598 | Phase 1 Clinical | Arcus Biosciences Inc | Ovarian Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | 詳細 |
| Eurestobart | ES-002023 | Phase 1 Clinical | Solid tumours | 詳細 | |
| ES-002 | ES-002 | Phase 1 Clinical | Solid tumours; Neoplasms | 詳細 |